Two Sigma Investments’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$893K Buy
1,144,565
+690,122
+152% +$583K ﹤0.01% 3345
2025
Q4
$356K Buy
454,443
+243,443
+115% +$200K ﹤0.01% 3502
2025
Q3
$152K Buy
211,000
+179,672
+574% +$814K ﹤0.01% 3418
2025
Q2
$159K Buy
31,328
+9,089
+41% +$35.8K ﹤0.01% 2951
2025
Q1
$67.2K Buy
22,239
+611
+3% +$2.23K ﹤0.01% 3009
2024
Q4
$78.3K Buy
+21,628
New +$65.5K ﹤0.01% 2996
2024
Q2
Sell
-10,088
Closed -$19.7K 3406
2024
Q1
$19.7K Sell
10,088
-16,450
-62% -$28.7K ﹤0.01% 2932
2023
Q4
$37.4K Sell
26,538
-65,794
-71% -$84.4K ﹤0.01% 3018
2023
Q3
$146K Sell
92,332
-328,258
-78% -$607K ﹤0.01% 2699
2023
Q2
$908K Buy
420,590
+294,974
+235% +$644K ﹤0.01% 1995
2023
Q1
$264K Sell
125,616
-36,922
-23% -$80.9K ﹤0.01% 2476
2022
Q4
$356K Sell
162,538
-17,476
-10% -$41.2K ﹤0.01% 2175
2022
Q3
$540K Buy
180,014
+1,457
+0.8% +$4.88K ﹤0.01% 1744
2022
Q2
$505K Sell
178,557
-56,680
-24% -$205K ﹤0.01% 1824
2022
Q1
$1.26M Sell
235,237
-251,756
-52% -$1.43M ﹤0.01% 1594
2021
Q4
$3.64M Sell
486,993
-54,728
-10% -$457K 0.01% 1411
2021
Q3
$4.92M Buy
541,721
+527,275
+3,650% +$3.15M 0.01% 1240
2021
Q2
$70K Buy
+14,446
New +$61.5K ﹤0.01% 3936
2021
Q1
Sell
-46,826
Closed -$182K 4498
2020
Q4
$182K Sell
46,826
-105,648
-69% -$386K ﹤0.01% 3128
2020
Q3
$492K Buy
152,474
+20,351
+15% +$83.6K ﹤0.01% 2262
2020
Q2
$587K Buy
132,123
+67,854
+106% +$246K ﹤0.01% 1887
2020
Q1
$180K Buy
+64,269
New +$277K ﹤0.01% 2694
2019
Q3
Sell
-2,792
Closed -$14K 4035
2019
Q2
$14K Sell
2,792
-2,015
-42% -$13.7K ﹤0.01% 3266
2019
Q1
$37K Sell
4,807
-2,921
-38% -$20.8K ﹤0.01% 2948
2018
Q4
$54K Buy
7,728
+315
+4% +$2.64K ﹤0.01% 2861
2018
Q3
$84K Buy
7,413
+6,499
+711% +$71.1K ﹤0.01% 3086
2018
Q2
$12K Buy
+914
New +$21.7K ﹤0.01% 3244

Other funds holding ATYR